| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Complement Factor H | 18 | 2026 | 35 | 4.150 |
Why?
|
| Glomerulonephritis | 19 | 2022 | 80 | 3.790 |
Why?
|
| Receptors, Complement | 28 | 2014 | 46 | 3.550 |
Why?
|
| Complement System Proteins | 20 | 2025 | 87 | 3.310 |
Why?
|
| Complement Activation | 27 | 2026 | 88 | 2.970 |
Why?
|
| Antigen-Antibody Complex | 11 | 2026 | 89 | 2.590 |
Why?
|
| Kidney Glomerulus | 25 | 2016 | 121 | 2.460 |
Why?
|
| Complement Inactivator Proteins | 16 | 2021 | 27 | 2.250 |
Why?
|
| Complement C3 | 20 | 2020 | 62 | 2.100 |
Why?
|
| Kidney | 23 | 2022 | 1121 | 1.970 |
Why?
|
| Lupus Nephritis | 9 | 2013 | 85 | 1.760 |
Why?
|
| Receptor, Anaphylatoxin C5a | 10 | 2020 | 21 | 1.640 |
Why?
|
| Receptors, Complement 3b | 22 | 2010 | 39 | 1.580 |
Why?
|
| Kidney Diseases | 11 | 2021 | 313 | 1.570 |
Why?
|
| Lupus Erythematosus, Systemic | 14 | 2017 | 244 | 1.500 |
Why?
|
| Immune Complex Diseases | 6 | 2022 | 19 | 1.340 |
Why?
|
| Animals | 113 | 2026 | 28950 | 1.270 |
Why?
|
| Immunoglobulin G | 14 | 2015 | 480 | 1.240 |
Why?
|
| Mice | 77 | 2022 | 12718 | 1.230 |
Why?
|
| Complement C3a | 4 | 2018 | 12 | 1.190 |
Why?
|
| Complement C5a | 10 | 2020 | 24 | 1.150 |
Why?
|
| Disease Models, Animal | 26 | 2018 | 2575 | 1.130 |
Why?
|
| Glomerulonephritis, Membranous | 5 | 2013 | 24 | 1.110 |
Why?
|
| Mice, Inbred C57BL | 33 | 2022 | 3612 | 0.960 |
Why?
|
| Diabetic Nephropathies | 4 | 2011 | 94 | 0.880 |
Why?
|
| Serum Sickness | 6 | 2015 | 12 | 0.850 |
Why?
|
| Reperfusion Injury | 5 | 2014 | 148 | 0.830 |
Why?
|
| Graft Rejection | 2 | 2026 | 1186 | 0.760 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 5 | 2016 | 12 | 0.760 |
Why?
|
| Blood Platelets | 6 | 2010 | 153 | 0.750 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 7 | 2012 | 18 | 0.740 |
Why?
|
| CD55 Antigens | 3 | 2009 | 21 | 0.730 |
Why?
|
| Apoptosis | 17 | 2016 | 1752 | 0.730 |
Why?
|
| Organ Transplantation | 1 | 2026 | 306 | 0.730 |
Why?
|
| CD59 Antigens | 7 | 2009 | 17 | 0.720 |
Why?
|
| Mice, Inbred MRL lpr | 16 | 2016 | 37 | 0.710 |
Why?
|
| Acute Kidney Injury | 6 | 2004 | 360 | 0.680 |
Why?
|
| Mice, Knockout | 21 | 2022 | 2209 | 0.680 |
Why?
|
| Monocytes | 3 | 2018 | 219 | 0.660 |
Why?
|
| Complement C5 | 3 | 2011 | 14 | 0.640 |
Why?
|
| Brain | 13 | 2016 | 2431 | 0.640 |
Why?
|
| Up-Regulation | 9 | 2017 | 743 | 0.630 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2021 | 268 | 0.620 |
Why?
|
| Glomerular Mesangium | 4 | 2008 | 22 | 0.620 |
Why?
|
| Rats | 26 | 2012 | 4073 | 0.600 |
Why?
|
| Neutrophils | 6 | 2009 | 346 | 0.580 |
Why?
|
| Podocytes | 6 | 2012 | 35 | 0.560 |
Why?
|
| Kidney Failure, Chronic | 4 | 2021 | 448 | 0.530 |
Why?
|
| Kidney Transplantation | 8 | 2026 | 942 | 0.530 |
Why?
|
| CD11b Antigen | 2 | 2015 | 35 | 0.520 |
Why?
|
| Gene Expression Regulation | 8 | 2014 | 2020 | 0.510 |
Why?
|
| Inflammation | 8 | 2018 | 1129 | 0.490 |
Why?
|
| Brain Diseases, Metabolic | 2 | 2007 | 8 | 0.490 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2008 | 700 | 0.490 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2009 | 38 | 0.490 |
Why?
|
| Nephritis, Interstitial | 5 | 2011 | 44 | 0.470 |
Why?
|
| Leukocytes | 3 | 2015 | 213 | 0.470 |
Why?
|
| Apoferritins | 7 | 2022 | 15 | 0.460 |
Why?
|
| Amino Acids | 2 | 2007 | 247 | 0.450 |
Why?
|
| Carboxypeptidases | 1 | 2015 | 34 | 0.450 |
Why?
|
| Receptors, Cell Surface | 11 | 2005 | 291 | 0.440 |
Why?
|
| Macrophages | 6 | 2022 | 643 | 0.440 |
Why?
|
| Cells, Cultured | 16 | 2017 | 2856 | 0.440 |
Why?
|
| Hepatitis B | 1 | 2015 | 78 | 0.430 |
Why?
|
| NF-kappa B | 6 | 2015 | 423 | 0.430 |
Why?
|
| Hepatitis C | 2 | 2015 | 186 | 0.430 |
Why?
|
| Receptors, IgG | 1 | 2015 | 70 | 0.420 |
Why?
|
| Complement Pathway, Alternative | 4 | 2021 | 13 | 0.410 |
Why?
|
| Neutrophil Infiltration | 3 | 2009 | 32 | 0.410 |
Why?
|
| Endothelium, Vascular | 5 | 2016 | 440 | 0.400 |
Why?
|
| Blood-Brain Barrier | 6 | 2015 | 87 | 0.400 |
Why?
|
| Kidney Tubules | 3 | 2010 | 91 | 0.400 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2013 | 23 | 0.400 |
Why?
|
| Receptors, Complement 3d | 6 | 2009 | 14 | 0.390 |
Why?
|
| T-Lymphocytes | 4 | 2012 | 1333 | 0.390 |
Why?
|
| Glucose | 2 | 2007 | 704 | 0.380 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2014 | 2569 | 0.380 |
Why?
|
| RNA, Messenger | 16 | 2010 | 2068 | 0.380 |
Why?
|
| Antibodies, Antinuclear | 3 | 2010 | 94 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2010 | 709 | 0.370 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2003 | 557 | 0.350 |
Why?
|
| Recombinant Proteins | 5 | 2005 | 994 | 0.350 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2009 | 60 | 0.350 |
Why?
|
| Mice, Inbred BALB C | 7 | 2010 | 1110 | 0.340 |
Why?
|
| Erythrocytes | 2 | 2010 | 242 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2011 | 1290 | 0.340 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 87 | 0.330 |
Why?
|
| Membrane Glycoproteins | 4 | 2004 | 446 | 0.330 |
Why?
|
| Ureteral Obstruction | 2 | 2013 | 62 | 0.320 |
Why?
|
| Gene Expression Profiling | 7 | 2014 | 1566 | 0.320 |
Why?
|
| MicroRNAs | 3 | 2014 | 607 | 0.320 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2010 | 25 | 0.320 |
Why?
|
| Lipopolysaccharides | 5 | 2007 | 313 | 0.310 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2007 | 40 | 0.310 |
Why?
|
| Signal Transduction | 11 | 2016 | 3627 | 0.300 |
Why?
|
| Receptors, Fc | 1 | 2009 | 38 | 0.290 |
Why?
|
| Mesangial Cells | 1 | 2009 | 9 | 0.290 |
Why?
|
| Pichia | 3 | 2003 | 33 | 0.290 |
Why?
|
| Mice, Transgenic | 10 | 2010 | 1606 | 0.290 |
Why?
|
| Serum Albumin | 1 | 2009 | 126 | 0.290 |
Why?
|
| Humans | 44 | 2026 | 98223 | 0.290 |
Why?
|
| Clusterin | 2 | 2008 | 13 | 0.290 |
Why?
|
| Antigens, Surface | 10 | 2005 | 100 | 0.280 |
Why?
|
| Complement Factor B | 2 | 2012 | 9 | 0.280 |
Why?
|
| RNA Splicing | 1 | 2010 | 163 | 0.280 |
Why?
|
| Blood Urea Nitrogen | 4 | 2010 | 33 | 0.280 |
Why?
|
| Kidney Function Tests | 4 | 2016 | 123 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 213 | 0.270 |
Why?
|
| Fibronectins | 1 | 2008 | 104 | 0.270 |
Why?
|
| bcl-X Protein | 1 | 2007 | 57 | 0.270 |
Why?
|
| Atherosclerosis | 1 | 2011 | 273 | 0.270 |
Why?
|
| Sepsis | 3 | 2007 | 402 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 403 | 0.260 |
Why?
|
| Encephalitis | 1 | 2007 | 45 | 0.260 |
Why?
|
| Antigens, CD | 2 | 2002 | 484 | 0.260 |
Why?
|
| Male | 34 | 2026 | 47195 | 0.250 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2021 | 661 | 0.250 |
Why?
|
| Dysbiosis | 2 | 2018 | 103 | 0.240 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2006 | 23 | 0.240 |
Why?
|
| Behavior, Animal | 2 | 2007 | 398 | 0.240 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 164 | 0.240 |
Why?
|
| Muscle, Skeletal | 3 | 2020 | 523 | 0.240 |
Why?
|
| Endotoxemia | 2 | 2004 | 19 | 0.240 |
Why?
|
| Lupus Vulgaris | 1 | 2005 | 4 | 0.240 |
Why?
|
| Albuminuria | 4 | 2009 | 54 | 0.230 |
Why?
|
| Transgenes | 3 | 2009 | 173 | 0.230 |
Why?
|
| Mice, Mutant Strains | 4 | 2009 | 217 | 0.220 |
Why?
|
| Bone Marrow Cells | 1 | 2006 | 269 | 0.220 |
Why?
|
| Vitamin D | 2 | 2007 | 286 | 0.210 |
Why?
|
| Diacylglycerol Kinase | 2 | 2016 | 5 | 0.210 |
Why?
|
| Autoimmune Diseases | 2 | 2004 | 260 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2007 | 1255 | 0.210 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2026 | 116 | 0.210 |
Why?
|
| Renal Insufficiency | 3 | 2011 | 101 | 0.200 |
Why?
|
| Aquaporins | 1 | 2003 | 14 | 0.200 |
Why?
|
| Complement Inactivating Agents | 2 | 2025 | 6 | 0.200 |
Why?
|
| Fibrosis | 4 | 2022 | 234 | 0.200 |
Why?
|
| Molecular Sequence Data | 8 | 2012 | 2894 | 0.200 |
Why?
|
| Base Sequence | 8 | 2012 | 2222 | 0.200 |
Why?
|
| Curcumin | 2 | 2013 | 18 | 0.190 |
Why?
|
| Bacteria | 2 | 2018 | 545 | 0.190 |
Why?
|
| Energy Metabolism | 1 | 2005 | 314 | 0.190 |
Why?
|
| Leukemia Virus, Murine | 1 | 2002 | 19 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2007 | 114 | 0.180 |
Why?
|
| Solubility | 5 | 2003 | 187 | 0.180 |
Why?
|
| Retroviridae | 1 | 2002 | 74 | 0.180 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 21 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 85 | 0.180 |
Why?
|
| Chemokines | 3 | 2007 | 79 | 0.180 |
Why?
|
| Gene Expression | 7 | 2020 | 1321 | 0.180 |
Why?
|
| Tissue Donors | 1 | 2026 | 581 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 889 | 0.170 |
Why?
|
| Pinocytosis | 1 | 2021 | 6 | 0.170 |
Why?
|
| Lymphocyte Depletion | 2 | 2013 | 103 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2005 | 1288 | 0.170 |
Why?
|
| Renal Circulation | 1 | 2001 | 31 | 0.170 |
Why?
|
| Cresols | 1 | 2021 | 17 | 0.170 |
Why?
|
| DNA Primers | 6 | 2008 | 530 | 0.170 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2010 | 92 | 0.170 |
Why?
|
| Antibodies | 4 | 2009 | 349 | 0.170 |
Why?
|
| Cytokines | 5 | 2017 | 890 | 0.170 |
Why?
|
| Chronic Disease | 4 | 2013 | 988 | 0.160 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2000 | 23 | 0.160 |
Why?
|
| Physical Endurance | 1 | 2020 | 13 | 0.160 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2002 | 190 | 0.160 |
Why?
|
| Receptors, Immunologic | 1 | 2001 | 143 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2025 | 618 | 0.160 |
Why?
|
| Endothelial Cells | 4 | 2021 | 502 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 2 | 2026 | 301 | 0.160 |
Why?
|
| Aorta | 1 | 2021 | 275 | 0.150 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 250 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2011 | 39 | 0.150 |
Why?
|
| Kidney Neoplasms | 1 | 2025 | 556 | 0.150 |
Why?
|
| Amino Acid Sequence | 7 | 2012 | 2003 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 3 | 2009 | 1417 | 0.150 |
Why?
|
| Endothelium | 2 | 2016 | 63 | 0.150 |
Why?
|
| Ischemia | 1 | 2001 | 263 | 0.150 |
Why?
|
| Cerebrospinal Fluid | 1 | 1999 | 24 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 842 | 0.140 |
Why?
|
| Uremia | 1 | 2018 | 14 | 0.140 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 1998 | 5 | 0.140 |
Why?
|
| Urea | 1 | 2018 | 54 | 0.140 |
Why?
|
| Cell Movement | 5 | 2022 | 816 | 0.140 |
Why?
|
| Astrocytes | 3 | 2015 | 142 | 0.140 |
Why?
|
| Complement C4 | 1 | 1998 | 8 | 0.140 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2017 | 2 | 0.130 |
Why?
|
| Disease Progression | 4 | 2022 | 1612 | 0.130 |
Why?
|
| Complement Membrane Attack Complex | 3 | 2007 | 21 | 0.130 |
Why?
|
| Heroin Dependence | 1 | 2017 | 16 | 0.130 |
Why?
|
| Brain Edema | 3 | 2007 | 55 | 0.130 |
Why?
|
| Glycation End Products, Advanced | 1 | 2017 | 12 | 0.130 |
Why?
|
| B-Lymphocytes | 4 | 2009 | 727 | 0.130 |
Why?
|
| Myeloid Cells | 1 | 2018 | 121 | 0.130 |
Why?
|
| Lymphocyte Activation | 4 | 2009 | 822 | 0.130 |
Why?
|
| Peritoneal Dialysis | 1 | 2017 | 34 | 0.130 |
Why?
|
| Macrophage-1 Antigen | 1 | 1997 | 18 | 0.130 |
Why?
|
| Pancreas | 1 | 1999 | 269 | 0.130 |
Why?
|
| Regeneration | 1 | 2018 | 163 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 2012 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2017 | 128 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 272 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2013 | 358 | 0.120 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2016 | 7 | 0.120 |
Why?
|
| Microglia | 1 | 2017 | 131 | 0.120 |
Why?
|
| Autoimmunity | 3 | 2017 | 195 | 0.120 |
Why?
|
| HIV-1 | 1 | 2017 | 179 | 0.120 |
Why?
|
| Liver | 1 | 2021 | 1230 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 391 | 0.120 |
Why?
|
| Epithelial Cells | 3 | 2007 | 710 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2012 | 403 | 0.120 |
Why?
|
| Fracture Healing | 2 | 2007 | 48 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2018 | 320 | 0.120 |
Why?
|
| Receptors, Calcitriol | 2 | 2007 | 130 | 0.120 |
Why?
|
| Aquaporin 4 | 2 | 2007 | 10 | 0.120 |
Why?
|
| Dinoprostone | 1 | 2016 | 80 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 102 | 0.120 |
Why?
|
| Diet | 2 | 2017 | 469 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2018 | 356 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2007 | 271 | 0.110 |
Why?
|
| Extracellular Matrix | 3 | 2007 | 259 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2007 | 152 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 201 | 0.110 |
Why?
|
| Glycolysis | 2 | 2007 | 198 | 0.110 |
Why?
|
| Comorbidity | 2 | 2017 | 1033 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2007 | 94 | 0.110 |
Why?
|
| C-Reactive Protein | 2 | 2007 | 217 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2015 | 22 | 0.110 |
Why?
|
| Complement C3d | 2 | 2007 | 6 | 0.110 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 76 | 0.110 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2006 | 7 | 0.110 |
Why?
|
| Sheep | 2 | 2009 | 204 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2005 | 69 | 0.100 |
Why?
|
| Female | 13 | 2026 | 51685 | 0.100 |
Why?
|
| Proteinuria | 3 | 2012 | 72 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2007 | 1145 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2026 | 2598 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 3 | 2007 | 357 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2015 | 421 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2015 | 369 | 0.090 |
Why?
|
| Caspase 3 | 2 | 2016 | 161 | 0.090 |
Why?
|
| DNA, Complementary | 2 | 2003 | 380 | 0.090 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 582 | 0.090 |
Why?
|
| Nephritis | 1 | 2012 | 17 | 0.090 |
Why?
|
| Precipitin Tests | 3 | 1997 | 101 | 0.090 |
Why?
|
| Microbiota | 1 | 2017 | 472 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2007 | 370 | 0.090 |
Why?
|
| Gliosis | 2 | 2009 | 32 | 0.080 |
Why?
|
| Protein Isoforms | 2 | 2010 | 303 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 255 | 0.080 |
Why?
|
| Blotting, Northern | 3 | 1995 | 239 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2010 | 291 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2010 | 779 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2010 | 37 | 0.080 |
Why?
|
| Species Specificity | 3 | 2004 | 690 | 0.080 |
Why?
|
| Leukocyte Common Antigens | 2 | 2007 | 50 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2013 | 506 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 822 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2018 | 310 | 0.080 |
Why?
|
| Wound Healing | 2 | 2016 | 384 | 0.080 |
Why?
|
| Cholesterol | 2 | 2021 | 376 | 0.080 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 13 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 1816 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2026 | 9750 | 0.080 |
Why?
|
| Microvilli | 1 | 2009 | 44 | 0.070 |
Why?
|
| Organic Chemicals | 1 | 2009 | 38 | 0.070 |
Why?
|
| Annexin A4 | 1 | 2009 | 2 | 0.070 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 565 | 0.070 |
Why?
|
| Calcitriol | 2 | 2007 | 173 | 0.070 |
Why?
|
| Heymann Nephritis Antigenic Complex | 2 | 2001 | 3 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 59 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2010 | 420 | 0.070 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 153 | 0.070 |
Why?
|
| Protein Phosphatase 2C | 1 | 2008 | 6 | 0.070 |
Why?
|
| Femoral Fractures | 2 | 2007 | 37 | 0.070 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 17 | 0.070 |
Why?
|
| Albumins | 1 | 2009 | 126 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2009 | 278 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 2010 | 184 | 0.070 |
Why?
|
| Antibody Formation | 1 | 2009 | 172 | 0.070 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2008 | 58 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2009 | 1790 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2009 | 205 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 187 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2008 | 7 | 0.070 |
Why?
|
| Cytochromes c | 1 | 2007 | 28 | 0.070 |
Why?
|
| Mice, Inbred NOD | 1 | 2008 | 228 | 0.070 |
Why?
|
| HIV Infections | 1 | 2017 | 1018 | 0.070 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2007 | 16 | 0.070 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 39 | 0.070 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2007 | 55 | 0.070 |
Why?
|
| I-kappa B Kinase | 1 | 2007 | 42 | 0.070 |
Why?
|
| Serum Albumin, Bovine | 1 | 2007 | 46 | 0.070 |
Why?
|
| Proteins | 2 | 2003 | 803 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2007 | 44 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2008 | 155 | 0.070 |
Why?
|
| Cell Survival | 1 | 2010 | 1016 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 68 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 257 | 0.070 |
Why?
|
| Autoantibodies | 3 | 2009 | 286 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2007 | 38 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2007 | 25 | 0.070 |
Why?
|
| CD40 Antigens | 1 | 2007 | 43 | 0.070 |
Why?
|
| Citric Acid Cycle | 1 | 2007 | 32 | 0.070 |
Why?
|
| Thrombin | 1 | 2007 | 60 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2007 | 95 | 0.060 |
Why?
|
| Mice, Nude | 1 | 2009 | 830 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2007 | 110 | 0.060 |
Why?
|
| Prognosis | 1 | 2015 | 4126 | 0.060 |
Why?
|
| Horses | 1 | 2007 | 35 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2007 | 22 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 1569 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 45 | 0.060 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2006 | 12 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 197 | 0.060 |
Why?
|
| Calbindin 1 | 1 | 2006 | 8 | 0.060 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2006 | 7 | 0.060 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2006 | 10 | 0.060 |
Why?
|
| Calbindins | 1 | 2006 | 16 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 1997 | 73 | 0.060 |
Why?
|
| Adipocytes | 1 | 2008 | 180 | 0.060 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2006 | 19 | 0.060 |
Why?
|
| Immediate-Early Proteins | 2 | 2007 | 160 | 0.060 |
Why?
|
| Molecular Weight | 2 | 1997 | 280 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2006 | 45 | 0.060 |
Why?
|
| Actins | 2 | 2020 | 480 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2007 | 177 | 0.060 |
Why?
|
| Complement C9 | 1 | 2005 | 3 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2007 | 529 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 315 | 0.060 |
Why?
|
| Biomarkers | 2 | 2026 | 2020 | 0.060 |
Why?
|
| Feces | 2 | 2018 | 389 | 0.060 |
Why?
|
| Carbon Radioisotopes | 1 | 2005 | 28 | 0.060 |
Why?
|
| Choline | 1 | 2005 | 23 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 480 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 42 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 215 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2005 | 47 | 0.060 |
Why?
|
| Alanine | 1 | 2005 | 82 | 0.060 |
Why?
|
| Nephrotic Syndrome | 1 | 2005 | 34 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2005 | 95 | 0.050 |
Why?
|
| Arginine | 1 | 2005 | 143 | 0.050 |
Why?
|
| Protons | 1 | 2005 | 102 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2007 | 164 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2005 | 136 | 0.050 |
Why?
|
| Databases, Protein | 1 | 2005 | 52 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2005 | 45 | 0.050 |
Why?
|
| Glutamine | 1 | 2005 | 99 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 151 | 0.050 |
Why?
|
| Cryoglobulins | 1 | 2004 | 4 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2010 | 122 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1647 | 0.050 |
Why?
|
| Antigens | 1 | 2005 | 225 | 0.050 |
Why?
|
| Oligonucleotide Probes | 1 | 2003 | 36 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 102 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 340 | 0.050 |
Why?
|
| Procollagen | 1 | 2003 | 9 | 0.050 |
Why?
|
| Ginsenosides | 1 | 2004 | 124 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2005 | 323 | 0.050 |
Why?
|
| Hippocampus | 1 | 2007 | 465 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2004 | 94 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2003 | 46 | 0.050 |
Why?
|
| Complement Pathway, Classical | 1 | 2003 | 2 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 370 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 314 | 0.050 |
Why?
|
| Phenotype | 3 | 2018 | 2653 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 303 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 573 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 106 | 0.050 |
Why?
|
| Nephrosis | 1 | 2002 | 3 | 0.050 |
Why?
|
| Puromycin Aminonucleoside | 1 | 2002 | 3 | 0.050 |
Why?
|
| Mice, Inbred NZB | 1 | 2002 | 13 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2002 | 11 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 28 | 0.050 |
Why?
|
| Rats, Inbred Lew | 2 | 2004 | 219 | 0.050 |
Why?
|
| Vasculitis | 1 | 2003 | 42 | 0.050 |
Why?
|
| Dermatitis | 1 | 2003 | 34 | 0.050 |
Why?
|
| Liver Failure | 1 | 2003 | 72 | 0.050 |
Why?
|
| Proteomics | 1 | 2005 | 279 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 22 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 281 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 290 | 0.050 |
Why?
|
| Anemia, Hemolytic | 1 | 2002 | 17 | 0.050 |
Why?
|
| Renin-Angiotensin System | 1 | 2002 | 86 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2002 | 78 | 0.040 |
Why?
|
| Clodronic Acid | 1 | 2022 | 9 | 0.040 |
Why?
|
| Models, Biological | 1 | 2009 | 1805 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2002 | 147 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 124 | 0.040 |
Why?
|
| Graft Survival | 1 | 2026 | 994 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2002 | 122 | 0.040 |
Why?
|
| Complement C5b | 1 | 2001 | 2 | 0.040 |
Why?
|
| Complement C3b | 1 | 2001 | 5 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2005 | 287 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 1063 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2002 | 287 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2022 | 85 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2002 | 149 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2001 | 69 | 0.040 |
Why?
|
| Calcium | 1 | 2006 | 1201 | 0.040 |
Why?
|
| Mutation | 1 | 2012 | 4408 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2020 | 9 | 0.040 |
Why?
|
| Computational Biology | 1 | 2005 | 615 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 234 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2001 | 161 | 0.040 |
Why?
|
| Vimentin | 1 | 2020 | 47 | 0.040 |
Why?
|
| Age Factors | 1 | 2005 | 1972 | 0.040 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 88 | 0.040 |
Why?
|
| Muscle Fatigue | 1 | 2020 | 23 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 665 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2020 | 53 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 675 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2004 | 914 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 143 | 0.040 |
Why?
|
| Fermentation | 1 | 2000 | 16 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2005 | 1017 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2004 | 482 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2020 | 211 | 0.040 |
Why?
|
| Hemolysis | 1 | 2000 | 66 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2021 | 182 | 0.040 |
Why?
|
| Middle Aged | 3 | 2026 | 29494 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2000 | 273 | 0.040 |
Why?
|
| Chemokine CXCL2 | 2 | 2010 | 16 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2025 | 826 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2002 | 1528 | 0.030 |
Why?
|
| Genomics | 1 | 2005 | 902 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2018 | 42 | 0.030 |
Why?
|
| Urease | 1 | 2018 | 3 | 0.030 |
Why?
|
| Osteoclasts | 1 | 2018 | 36 | 0.030 |
Why?
|
| Ribotyping | 1 | 2018 | 12 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2018 | 97 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2002 | 568 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2018 | 145 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 3 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 109 | 0.030 |
Why?
|
| Immunization | 1 | 1998 | 154 | 0.030 |
Why?
|
| Mating Factor | 1 | 1997 | 4 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 65 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1997 | 60 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1997 | 38 | 0.030 |
Why?
|
| Cadaver | 1 | 2017 | 203 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1997 | 42 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 1998 | 435 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 1126 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 169 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 649 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 1999 | 374 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 675 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 2016 | 43 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 1261 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 249 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1997 | 426 | 0.030 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2015 | 3 | 0.030 |
Why?
|
| Claudin-5 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 64 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 80 | 0.030 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2015 | 70 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 474 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 147 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 125 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 894 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 119 | 0.030 |
Why?
|
| Neurons | 3 | 2010 | 1621 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2015 | 118 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2017 | 386 | 0.030 |
Why?
|
| DNA | 2 | 2012 | 1274 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 130 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 145 | 0.030 |
Why?
|
| Glycosylation | 1 | 1995 | 141 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 970 | 0.030 |
Why?
|
| Spleen | 1 | 1995 | 376 | 0.030 |
Why?
|
| Epithelium | 1 | 1995 | 316 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2015 | 158 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 2379 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 447 | 0.020 |
Why?
|
| Peptides | 1 | 1997 | 670 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 479 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 2015 | 201 | 0.020 |
Why?
|
| Atrophy | 1 | 2013 | 131 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2013 | 227 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1995 | 224 | 0.020 |
Why?
|
| Diglycerides | 1 | 2012 | 20 | 0.020 |
Why?
|
| Turkey | 1 | 2012 | 23 | 0.020 |
Why?
|
| Consanguinity | 1 | 2012 | 75 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2011 | 84 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 3611 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 153 | 0.020 |
Why?
|
| Child | 2 | 2015 | 7730 | 0.020 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2010 | 20 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2026 | 11031 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 983 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 770 | 0.020 |
Why?
|
| Clone Cells | 1 | 2010 | 221 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 718 | 0.020 |
Why?
|
| Germinal Center | 1 | 2010 | 66 | 0.020 |
Why?
|
| Plasma Cells | 1 | 2010 | 89 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2482 | 0.020 |
Why?
|
| Adult | 2 | 2026 | 29548 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 78 | 0.020 |
Why?
|
| Adolescent | 2 | 2015 | 10127 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2009 | 18 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 220 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2009 | 72 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 194 | 0.020 |
Why?
|
| Azo Compounds | 1 | 2008 | 14 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 37 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2008 | 47 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2007 | 4 | 0.020 |
Why?
|
| Luciferases | 1 | 2008 | 128 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 102 | 0.020 |
Why?
|
| Streptozocin | 1 | 2007 | 56 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 479 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2007 | 79 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 304 | 0.020 |
Why?
|
| Chemokine CXCL1 | 1 | 2007 | 9 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2007 | 95 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 525 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2007 | 53 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2007 | 62 | 0.020 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 34 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 388 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 218 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 258 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 207 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2007 | 286 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 1452 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2008 | 290 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 3217 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 5573 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2009 | 552 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2004 | 25 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 52 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 2570 | 0.010 |
Why?
|
| Survival | 1 | 2004 | 22 | 0.010 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2004 | 12 | 0.010 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2004 | 16 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 52 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 3348 | 0.010 |
Why?
|
| Protein Binding | 1 | 2007 | 1557 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2004 | 124 | 0.010 |
Why?
|
| Neutron Diffraction | 1 | 2003 | 5 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 34 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 202 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2003 | 63 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 679 | 0.010 |
Why?
|
| Solutions | 1 | 2003 | 84 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 4026 | 0.010 |
Why?
|
| Liver Regeneration | 1 | 2003 | 33 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2003 | 131 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2002 | 35 | 0.010 |
Why?
|
| Sclerosis | 1 | 2002 | 30 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 889 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2894 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 690 | 0.010 |
Why?
|
| Angiotensin II | 1 | 2002 | 96 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 426 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 860 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 731 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 290 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1946 | 0.010 |
Why?
|
| Insulin | 1 | 2004 | 1224 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1392 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 7556 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 2789 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 1717 | 0.010 |
Why?
|